Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Rapid Micro Biosystems, Inc. (RPID) announced its participation in upcoming investor conferences, including TD Cowen 44th Annual Healthcare Conference and KeyBanc Life Sciences & MedTech Investor Forum. The Company will engage in question-and-answer sessions with host analysts, providing live webcasts accessible on their investor relations website for replay.

LOWELL, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences:

• TD Cowen 44^th Annual Healthcare Conference
  Question-and-answer session with the host analyst on Tuesday, March 5, 2024, at 1:30 p.m. ET in Boston, Massachusetts.
  

• KeyBanc Life Sciences & MedTech Investor Forum (Virtual)
  Question-and-answer session with the host analyst on Tuesday, March 19, 2024, at 3:00 p.m. ET.
  

Live webcasts for both events will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcasts will be archived and available for replay after the event.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct System automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct System brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Lexington, Massachusetts, Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on Twitter at @rapidmicrobio or on LinkedIn.

FAQ

When will Rapid Micro Biosystems participate in the TD Cowen 44th Annual Healthcare Conference?

Rapid Micro Biosystems will participate in the TD Cowen 44th Annual Healthcare Conference on Tuesday, March 5, 2024, at 1:30 p.m. ET in Boston, Massachusetts.

What is the KeyBanc Life Sciences & MedTech Investor Forum?

The KeyBanc Life Sciences & MedTech Investor Forum is a virtual event where Rapid Micro Biosystems will engage in a question-and-answer session with the host analyst on Tuesday, March 19, 2024, at 3:00 p.m. ET.

Where can investors access the live webcasts for the upcoming events?

Investors can access the live webcasts for the upcoming events on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/. The webcasts will also be archived for replay after the events.